Sageworth Trust Company »

Vertex Pharmaceuticals Incorporated shares owned by Sageworth Trust Company

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Sageworth Trust Company from 13F filings

Historical chart of Sageworth Trust Company investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Sageworth Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Sageworth Trust Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $220k 561 391.64
2024-06-30 $357k 762 468.72
2017-12-31 $1.0k 7 142.86

More positions owned by Sageworth Trust Company

Vanguard Us Total Stock Mkt Sh Etf (VTI)
Vanguard Total International S Etf (VXUS)
Ishares Msci Acwi Etf Etf (ACWI)
Vanguard S&p 500 Etf Etf (VOO)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Acwi Ex Us Etf (ACWX)
Vanguard Total World Stock Etf Etf (VT)
Dimensional U.s. Small Cap Etf Etf (DFAS)
Vanguard Ftse Developed Market Etf (VEA)
Vanguard Value Etf Etf (VTV)
Dimensional Etf Trust Internat Etf (DFIC)
Ishares Core S&p 500 Etf Etf (IVV)
Dimensional Etf Trust Us Core Etf (DCOR)
Dimensional Etf Trust Emerging Etf (DFEM)
Invesco S&p 500 Equal Weight E Etf (RSP)

View all positions for Sageworth Trust Company

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated